Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 47, 2017 - Issue 5
248
Views
7
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Identification of UDP-glucuronosyltransferases 1A1, 1A3 and 2B15 as the main contributors to glucuronidation of bakuchiol, a natural biologically active compound

, , , , &
Pages 369-375 | Received 24 Apr 2016, Accepted 25 May 2016, Published online: 17 Jun 2016

References

  • Backhouse CN, Delporte CL, Negrete RE, et al. (2001). Active constituents isolated from Psoralea glandulosa L. with antiinflammatory and antipyretic activities. J Ethnopharmacol 78:27–31
  • Chaudhuri RK, Bojanowski K. (2014). Bakuchiol: a retinol-like functional compound revealed by gene expression profiling and clinically proven to have anti-aging effects. Int J Cosmet Sci 36:221–30
  • Chen Z, Jin K, Gao L, et al. (2010). Anti-tumor effects of bakuchiol, an analogue of resveratrol, on human lung adenocarcinoma A549 cell line. Eur J Pharmacol 643:170–9
  • Choi SY, Lee S, Choi WH, et al. (2010). Isolation and anti-inflammatory activity of Bakuchiol from Ulmus davidiana var. japonica. J Med Food 13:1019–23
  • Court MH. (2005). Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases. Meth Enzymol 400:104–16
  • Court MH, Duan SX, Guillemette C, et al. (2002). Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9. Drug Metab Dispos 30:1257–65
  • Dong D, Zhang T, Lu D, et al. (2016). In vitro characterization of belinostat glucuronidation: demonstration of both UGT1A1 and UGT2B7 as the main contributing isozymes. Xenobiotica 16:1–7
  • Dong D, Zhang Y, Zhang S, et al. (2014). Inhibition potential of UDP-glucuronosyltransferases (UGTs) 1A isoforms by the analogue of resveratrol, bakuchiol. Pharmazie 69:60–3
  • Evans WE, Relling MV. (1999). Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286:487–91
  • Fallon JK, Neubert H, Goosen TC, Smith PC. (2013). Targeted precise quantification of 12 human recombinant uridine-diphosphate glucuronosyl transferase 1A and 2B isoforms using nano-ultra-high-performance liquid chromatography/tandem mass spectrometry with selected reaction monitoring. Drug Metab Dispos 41:2076–80
  • Harrington WR, Sengupta S, Katzenellenbogen BS. (2006). Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells. Endocrinology 147:3843–50
  • Hu C, Liang Q, Tang X, et al. (2015). In vivo metabolite identification of bakuchiol in rats by UPLC/ESI-PDA-QTOF-MS. Fitoterapia 106:129–34
  • Hutzler JM, Tracy TS. (2002). Atypical kinetic profiles in drug metabolism reactions. Drug Metab Dispos 30:355–62
  • Katsura H, Tsukiyama RI, Suzuki A, Kobayashi M. (2001). In vitro antimicrobial activities of bakuchiol against oral microorganisms. Antimicrob Agents Chemother 45:3009–13
  • Kim JE, Kim JH, Lee Y, et al. (2016). Bakuchiol suppresses proliferation of skin cancer cells by directly targeting Hck, Blk, and p38 MAP kinase. Oncotarget 7:14616–27
  • King CD, Rios GR, Green MD, Tephly TR. (2000). UDP-glucuronosyltransferases. Curr Drug Metab 1:143–61
  • Kurkela M, Garcia-Horsman JA, Luukkanen L, et al. (2003). Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme. J Biol Chem 278:3536–44
  • Levesque E, Beaulieu M, Green MD, et al. (1997). Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317–25
  • Liu H, Wu Z, Ma Z, Wu B. (2014a). Glucuronidation of macelignan by human liver microsomes and expressed UGT enzymes: identification of UGT1A1 and 2B7 as the main contributing enzymes. Biopharm Drug Dispos 35:513–24
  • Liu W, Liu H, Sun H, et al. (2014b). Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS). Xenobiotica 44:455–64
  • Madrid A, Cardile V, Gonzalez C, et al. (2015). Psoralea glandulosa as a potential source of anticancer agents for melanoma treatment. Int J Mol Sci 16:7944–59
  • Ohno S, Nakajin S. (2009). Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 37:32–40
  • Wu B, Kulkarni K, Basu S, et al. (2011). First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. J Pharm Sci 100:3655–81
  • Xu Y, Li P, Zhang X, et al. (2014). In vitro evidence for bakuchiol's influence towards drug metabolism through inhibition of UDP-glucuronosyltransferase (UGT) 2B7. Afr Health Sci 14:564–9
  • Yang SK, Lu XL. (1991). N,N-dimethylcarbamyl derivatives of oxazepam. Chirality 3:212–19
  • Zhang JY, Zhan J, Cook CS, et al. (2003). Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. Drug Metab Dispos 31:652–8
  • Zhuang X, Zhong Y, Yuan M, Li H. (2013). Pre-column derivatization combined with UHPLC-MS/MS for rapid and sensitive quantification of bakuchiol in rat plasma. J Pharm Biomed Anal 75:18–24

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.